683 Capital Management, LLC Alnylam Pharmaceuticals, Inc. Put Options Transaction History

683 Capital Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2024 Feb 14, 2025	SELL	$232.27 - $300.43 $15 Million - $19.4 Million	-64,600 Reduced 52.39%	58,700 $13.8 Million
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $93,524 - $114,804	400 Added 0.33%	123,300 $33.9 Million
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $12.5 Million - $21.5 Million	87,100 Added 243.3%	122,900 $29.9 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $5.25 Million - $7.1 Million	35,800 New	35,800 $5.35 Million
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $1.71 Million - $2.12 Million	10,000 New	10,000 $1.77 Million

667

112M

839K

771K

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 683 Capital Management, LLC with notifications on news.